SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-024728
Filing Date
2021-05-06
Accepted
2021-05-06 13:00:51
Documents
69
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cbio-10q_20210331.htm   iXBRL 10-Q 1531347
2 EX-31.1 cbio-ex311_7.htm EX-31.1 14098
3 EX-31.2 cbio-ex312_11.htm EX-31.2 14074
4 EX-32.1 cbio-ex321_6.htm EX-32.1 9725
5 EX-32.2 cbio-ex322_10.htm EX-32.2 9702
6 GRAPHIC gigybemkqbb2000001.jpg GRAPHIC 71977
  Complete submission text file 0001564590-21-024728.txt   6043847

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA cbio-20210331.xsd EX-101.SCH 47749
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbio-20210331_cal.xml EX-101.CAL 36294
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbio-20210331_def.xml EX-101.DEF 121896
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20210331_lab.xml EX-101.LAB 333452
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20210331_pre.xml EX-101.PRE 252940
12 EXTRACTED XBRL INSTANCE DOCUMENT cbio-10q_20210331_htm.xml XML 1079670
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51173 | Film No.: 21896846
SIC: 2834 Pharmaceutical Preparations